Skip to content

Clinical trials

Adrenal Hyperplasia, Congenital trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenal Hyperplasia, Congenital Country / region: United States Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20074
20083
20091
20112
20121
20132
20151
20163
20172
20183
20192
20202
20215
20223
20233
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting9
Active, not recruiting4
Terminated4
Withdrawn4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurocrine UK Limited6
Neurocrine Biosciences5
Spruce Biosciences5
Crinetics Pharmaceuticals Inc.4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Mayo Clinic3
Adrenas Therapeutics Inc2
National Institutes of Health Clinical Center (CC)2
Office of Rare Diseases (ORD)2
University of Texas Southwestern Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenal Hyperplasia, Congenital50
Adrenal Gland Diseases5
ACTH Syndrome, Ectopic4
Disorders of Sex Development4
Adrenal Insufficiency3
Cushing Syndrome3
Adrenocortical Hyperfunction2
Adrenogenital Syndrome2
Endocrine System Diseases2
Genetic Diseases, Inborn2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.